Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1949 1
1951 1
1952 1
1954 1
1956 2
1960 1
1963 1
1966 4
1967 4
1968 7
1969 9
1970 1
1971 2
1972 6
1974 7
1975 5
1976 3
1977 11
1978 1
1979 7
1980 8
1981 12
1982 18
1983 6
1984 8
1985 15
1986 17
1987 16
1988 9
1989 13
1990 7
1991 12
1992 6
1993 11
1994 21
1995 29
1996 24
1997 19
1998 14
1999 11
2000 8
2001 13
2002 11
2003 14
2004 8
2005 15
2006 15
2007 18
2008 22
2009 38
2010 33
2011 39
2012 53
2013 54
2014 43
2015 47
2016 47
2017 42
2018 51
2019 47
2020 53
2021 63
2022 60
2023 67
2024 47

Text availability

Article attribute

Article type

Publication date

Search Results

1,152 results

Results by year

Filters applied: . Clear all
Page 1
Isatuximab in multiple myeloma.
Martino EA, Bruzzese A, Iaccino E, Mendicino F, Mimmi S, Lucia E, Olivito V, Neri A, Morabito F, Vigna E, Gentile M. Martino EA, et al. Among authors: neri a. Expert Opin Biol Ther. 2023 Apr;23(4):315-318. doi: 10.1080/14712598.2023.2193289. Epub 2023 Mar 24. Expert Opin Biol Ther. 2023. PMID: 36943846 No abstract available.
Elotuzumab in multiple myeloma.
Bruzzese A, Martino EA, Vigna E, Iaccino E, Mendicino F, Lucia E, Olivito V, Filippelli G, Neri A, Morabito F, Gentile M. Bruzzese A, et al. Among authors: neri a. Expert Opin Biol Ther. 2023 Jan;23(1):7-10. doi: 10.1080/14712598.2022.2145882. Epub 2022 Nov 14. Expert Opin Biol Ther. 2023. PMID: 36373842 No abstract available.
Belantamab mafodotin in multiple myeloma.
Martino EA, Bruzzese A, Iaccino E, Labanca C, Mendicino F, Mimmi S, Lucia E, Olivito V, Neri A, Morabito F, Vigna E, Gentile M. Martino EA, et al. Among authors: neri a. Expert Opin Biol Ther. 2023 Jul-Dec;23(11):1043-1047. doi: 10.1080/14712598.2023.2218543. Epub 2023 May 27. Expert Opin Biol Ther. 2023. PMID: 37227998 No abstract available.
Venetoclax in acute myeloid leukemia.
Bruzzese A, Martino EA, Mendicino F, Lucia E, Olivito V, Neri A, Morabito F, Vigna E, Gentile M. Bruzzese A, et al. Among authors: neri a. Expert Opin Investig Drugs. 2023 Apr;32(4):271-276. doi: 10.1080/13543784.2023.2193679. Epub 2023 Mar 23. Expert Opin Investig Drugs. 2023. PMID: 36933006 No abstract available.
Myelodysplastic syndromes with ring sideroblasts.
Bruzzese A, Vigna E, Martino EA, Mendicino F, Lucia E, Olivito V, Bova C, Barbato A, Filippelli G, Capodanno I, Neri A, Morabito F, Gentile M. Bruzzese A, et al. Among authors: neri a. Hematol Oncol. 2023 Oct;41(4):612-620. doi: 10.1002/hon.3125. Epub 2023 Feb 26. Hematol Oncol. 2023. PMID: 36794650 Review.
Targeting the immune microenvironment in Waldenström macroglobulinemia via halting the CD40/CD40-ligand axis.
Sacco A, Desantis V, Celay J, Giustini V, Rigali F, Savino FD, Cea M, Soncini D, Cagnetta A, Solimando AG, D'Aliberti D, Spinelli S, Ramazzotti D, Almici C, Todoerti K, Neri A, Anastasia A, Tucci A, Motta M, Chiarini M, Kawano Y, Martinez-Climent JA, Piazza R, Roccaro AM. Sacco A, et al. Among authors: neri a. Blood. 2023 May 25;141(21):2615-2628. doi: 10.1182/blood.2022019240. Blood. 2023. PMID: 36735903 Free article.
A MIR17HG-derived long noncoding RNA provides an essential chromatin scaffold for protein interaction and myeloma growth.
Morelli E, Fulciniti M, Samur MK, Ribeiro CF, Wert-Lamas L, Henninger JE, Gullà A, Aktas-Samur A, Todoerti K, Talluri S, Park WD, Federico C, Scionti F, Amodio N, Bianchi G, Johnstone M, Liu N, Gramegna D, Maisano D, Russo NA, Lin C, Tai YT, Neri A, Chauhan D, Hideshima T, Shammas MA, Tassone P, Gryaznov S, Young RA, Anderson KC, Novina CD, Loda M, Munshi NC. Morelli E, et al. Among authors: neri a. Blood. 2023 Jan 26;141(4):391-405. doi: 10.1182/blood.2022016892. Blood. 2023. PMID: 36126301 Free PMC article.
Targeting of mitochondrial fission through natural flavanones elicits anti-myeloma activity.
Torcasio R, Gallo Cantafio ME, Veneziano C, De Marco C, Ganino L, Valentino I, Occhiuzzi MA, Perrotta ID, Mancuso T, Conforti F, Rizzuti B, Martino EA, Gentile M, Neri A, Viglietto G, Grande F, Amodio N. Torcasio R, et al. Among authors: neri a. J Transl Med. 2024 Feb 27;22(1):208. doi: 10.1186/s12967-024-05013-0. J Transl Med. 2024. PMID: 38413989 Free PMC article.
Zanubrutinib for the treatment of chronic lymphocytic leukemia.
Bruzzese A, Martino EA, Labanca C, Mendicino F, Lucia E, Olivito V, Neri A, Morabito F, Vigna E, Gentile M. Bruzzese A, et al. Among authors: neri a. Expert Opin Pharmacother. 2023 Sep-Dec;24(13):1409-1413. doi: 10.1080/14656566.2023.2229734. Epub 2023 Jun 26. Expert Opin Pharmacother. 2023. PMID: 37350553 No abstract available.
Mitochondrial Determinants of Anti-Cancer Drug-Induced Cardiotoxicity.
Rocca C, De Francesco EM, Pasqua T, Granieri MC, De Bartolo A, Gallo Cantafio ME, Muoio MG, Gentile M, Neri A, Angelone T, Viglietto G, Amodio N. Rocca C, et al. Among authors: neri a. Biomedicines. 2022 Feb 22;10(3):520. doi: 10.3390/biomedicines10030520. Biomedicines. 2022. PMID: 35327322 Free PMC article. Review.
1,152 results